A few years ago physicians stumbled onto a substance isolated from soy beans called Phosphatidylcholine (which had been tested clinically 20 years prior in patients with severe coronary artery disease. 20 patients suffering with intractable chest pain, sustained on beta blockers and nitroglycerin products were entered into a program which consisted of an infusion over a period of 50-60 minutes, 3-5 times per week for a total of 30 treatments. 19 patients became symptom free and got off all their medicines.
Based on the above results, a medical research team at BAXAMED, in Switzerland, initiated their own clinical study on a small group of severely ill patients. Two of these patients already had 2 bypass operations and had been sent home to die, one patient had 2 angioplasties and was still suffering from angina pectoris, and a fourth patient was documented, by a thallium stress test, to have blood perfusion problems of his heart.
After Plaquex/ Phosphatidylcholine treatment, a stress test at the University Hospital in Basel, Switzerland showed almost normal perfusion of the heart in all patients.